Vocimagene amiretrorepvec

DB15331InvestigationalGene Therapies

Vocimagene amiretrorepvec is under investigation in clinical trial NCT02576665 (A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca...

Mechanism: Pharmacologically active on Cytosine deaminase
Curator reviewed
Code names: DB107-RRV · TOCA 511

Resolves to

Compound

UNIIDC4WO3WA4QCAS1300724-82-6

Targets

P25524codA

What you can answer from here — as of July 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

10Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Vocimagene amiretrorepvec, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account